反応 #1483116
ord-ad58bda64d674ce1aa41b2fa12c6883f
反応方程式
試薬
反応条件
後処理
- 1workup.ADDITIONadded to the polymer solution
- 2その他yielding a milky suspension as the organic phase
- 3その他to provide an emulsion
- 4その他The emulsion was collected directly into a 10 mM sodium phosphate (pH 8, 0° C., 150 mL) solvent extraction solution
- 5抽出to extract EtOAc
- 6ろ過Hardened microparticles were collected by filtration
- 7洗浄washed with water, air
- 8その他dried
- 9その他stored at 4° C
実験手順
PLGA polymer (MW 13,000, 180 mg) was dissolved in EtOAc (900 μL). Oxytocin acetate (20 mg) was dissolved in MeOH (100 μL) and added to the polymer solution yielding a milky suspension as the organic phase. The resulting organic phase was combined with a 1% PVA aqueous phase containing 5% EtOAc to provide an emulsion. The emulsion was collected directly into a 10 mM sodium phosphate (pH 8, 0° C., 150 mL) solvent extraction solution and stirred for four hours while warming to room temperature to extract EtOAc. Hardened microparticles were collected by filtration, washed with water, air dried and stored at 4° C. This provided formulation BL (143 mg, 71.5% yield) with a median particle size 44.0 μm. The core load (1.67%), encapsulation efficiency (16.7%) and in vitro burst (46.3%) were determined by RP-HPLC assay.